Pediatric Migraine Treatment Guidelines

Acute Treatment Options

• The American Academy of Neurology recommends ibuprofen as first-line acute therapy for children and adolescents with pediatric migraine, with triptans considered for adolescents with inadequate response to NSAIDs 1, 2
• For adolescents, triptans such as sumatriptan/naproxen oral combination, rizatriptan orally disintegrating tablets (ODT), and almotriptan oral may be considered if NSAIDs are ineffective 1, 2
• If one triptan is ineffective, trying another triptan or a NSAID-triptan combination may be beneficial 1
• Non-oral triptans may be considered for rapidly escalating headache pain or for patients with significant nausea/vomiting 1
• Early treatment of acute migraine is recommended for best results 1

Preventive Treatment Options

• The American Academy of Neurology recommends considering preventive treatments for children and adolescents with frequent, disabling, or medication-overuse headaches 1, 2
• Preventive medications such as amitriptyline combined with cognitive behavioral therapy, topiramate, and propranolol may be effective 1
• Medications with insufficient evidence or not recommended include divalproex sodium, onabotulinumtoxinA, amitriptyline alone, and nimodipine 1

Non-Pharmacologic Approaches

• Lifestyle modifications such as regular sleep schedule, regular meal times, and adequate hydration may be beneficial 3
• Stress management and avoidance of acute medication overuse are also important 1, 4
• Behavioral interventions such as relaxation techniques and cognitive behavioral therapy may be effective 4

Important Clinical Considerations

• Approximately two-thirds of pediatric migraine patients improve with standard therapy, but one-third may require more aggressive or innovative approaches 3
• When discussing preventive medications, acknowledging the placebo effect and discussing teratogenic effects of certain medications is important 1
• An individualized therapeutic approach considering developmental factors and potential psychiatric comorbidities is necessary 5
• Despite FDA approval for some medications, their recommendations in guidelines may be lukewarm due to study design limitations 5

Treatment Algorithm

• Accurate diagnosis and identification of triggers is essential 1
• Acute treatment with ibuprofen or acetaminophen should be started, with triptans added or switched to if necessary 1
• Preventive therapy should be considered if headaches are frequent, disabling, or significantly impact quality of life 1
• Non-pharmacologic approaches should be incorporated throughout treatment 4

Next-Line Headache Treatment in Pediatric Patients

Treatment Options

• For adolescents, nasal spray formulations of sumatriptan or zolmitriptan are effective, and bed rest alone may suffice for short-duration attacks in younger children, according to the American Academy of Neurology 6
• The American Academy of Neurology recommends avoiding divalproex sodium, especially in females of childbearing potential, due to teratogenicity, and onabotulinumtoxinA due to insufficient evidence in pediatrics 7
• The American College of Physicians advises against using opioids or butalbital for pediatric headache treatment, as they lead to dependency and rebound headaches, and recommends monitoring for medication overuse headache, with NSAIDs ≥15 days/month and triptans ≥10 days/month 8
• The American Academy of Family Physicians suggests that triptans are underutilized in adolescents and recommends their use, with only 6% of pediatric migraineurs and 13% of adolescents receiving them despite superior efficacy compared to NSAIDs, and notes that non-pharmacologic approaches, such as relaxation techniques and cognitive behavioral therapy, are recommended as first-line interventions 9

Adjunctive Measures

• The American Academy of Neurology recommends keeping a headache calendar to monitor frequency, severity, and medication use, which is essential for treatment 7

Combination Therapy

• The American College of Physicians suggests that combination NSAID/triptan therapy is more effective than either agent alone for moderate to severe headaches, which mirrors adult guidelines where adding a triptan to an NSAID provides superior pain relief 8

Guideline Recommendations for Pediatric Migraine Management

Preventive Therapy Indications

• Preventive treatment is advised when children experience migraine on ≥ 2 days per month despite optimized acute therapy, when attacks lead to frequent school absences, markedly impair quality of life, or result in medication overuse. American Academy of Neurology guidance supports these criteria. [10][11]

First‑Line Preventive Options (Excluding Cyproheptadine)

• The American Academy of Neurology does not list cyproheptadine among first‑line preventive agents for pediatric migraine; instead, it recommends amitriptyline combined with cognitive‑behavioral therapy, topiramate, and propranolol as the primary preventive choices. 11

Side‑Effect Surveillance for Cyproheptadine

• Clinicians should monitor for sedation, the most common adverse effect of antihistaminic agents. (Guideline‑based recommendation; strength not specified). 11
• Increased appetite and potential weight gain are recognized side effects of cyproheptadine. 10
• Anticholinergic effects (e.g., dry mouth, constipation) should also be assessed during therapy. 11

Placebo Response Considerations

• Pediatric migraine trials frequently demonstrate a high placebo response (often > 50%), indicating that placebo can be as effective as active preventive medications; this information should be incorporated into shared decision‑making. American Academy of Neurology highlights this phenomenon. 11

Acute Treatment Foundations

• All pediatric patients should receive optimized acute therapy with ibuprofen as the first‑line option; for adolescents who do not respond adequately to NSAIDs, triptans (e.g., sumatriptan nasal spray, zolmitriptan nasal spray, or rizatriptan orally disintegrating tablet) are recommended. American Academy of Neurology guidance. 11

Lifestyle Modifications

• Implement regular sleep schedules, consistent meal times, adequate hydration, and systematic trigger identification as core non‑pharmacologic strategies for migraine management. Recommendations from Nature Reviews Neurology. 10

Behavioral Interventions

• Incorporate cognitive‑behavioral therapy, relaxation techniques, and stress‑management strategies as foundational components of comprehensive migraine care. Endorsed by the American Academy of Neurology. 11